| Autoimmune Bullous Skin Diseases | Lifetime | 32 | US 15 | 99.48 |
| Skin Diseases and Diabetes | Lifetime | 8 | US 5 | 99.47 |
| Cutaneous lymphoproliferative disorders research | Lifetime | 25 | US 9 | 99.42 |
| Dermatological and COVID-19 studies | Lifetime | 6 | US 4 | 99.19 |
| Autoimmune and Inflammatory Disorders | Lifetime | 28 | US 11 | 99.38 |
| Eosinophilic Disorders and Syndromes | Lifetime | 96 | US 55 | 99.06 |
| COVID-19 Clinical Research Studies | Lifetime | 425 | US 109 | 98.28 |
| Nail Diseases and Treatments | Lifetime | 100 | US 46 | 98.89 |
| Parvovirus B19 Infection Studies | Lifetime | 94 | US 49 | 98.59 |
| Lymphoma Diagnosis and Treatment | Lifetime | 424 | US 207 | 98.88 |
| Systemic Sclerosis and Related Diseases | Lifetime | 180 | US 67 | 98.40 |
| Inflammatory Myopathies and Dermatomyositis | Lifetime | 95 | US 44 | 98.55 |
| Cutaneous Melanoma Detection and Management | Lifetime | 294 | US 130 | 97.89 |
| Cancer and Skin Lesions | Lifetime | 331 | US 157 | 97.28 |
| Drug-Induced Adverse Reactions | Lifetime | 217 | US 65 | 96.77 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 676 | US 286 | 97.38 |
| Systemic Lupus Erythematosus Research | Lifetime | 810 | US 268 | 97.70 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | Lifetime | 618 | US 264 | 97.05 |
| Tumors and Oncological Cases | Lifetime | 309 | US 189 | 97.22 |
| Vasculitis and related conditions | Lifetime | 310 | US 87 | 97.06 |
| Vascular Tumors and Angiosarcomas | Lifetime | 253 | US 136 | 96.70 |
| Urticaria and Related Conditions | Lifetime | 428 | US 139 | 96.53 |
| Histiocytic Disorders and Treatments | Lifetime | 137 | US 81 | 96.39 |
| Fungal Infections and Studies | Lifetime | 633 | US 237 | 96.27 |
| Dermatological and Skeletal Disorders | Lifetime | 300 | US 105 | 94.54 |
| Oral Health Pathology and Treatment | Lifetime | 661 | US 209 | 94.80 |
| CNS Lymphoma Diagnosis and Treatment | Lifetime | 531 | US 226 | 94.10 |
| Nonmelanoma Skin Cancer Studies | Lifetime | 853 | US 375 | 93.14 |
| melanin and skin pigmentation | Lifetime | 979 | US 344 | 92.50 |
| Melanoma and MAPK Pathways | Lifetime | 918 | US 444 | 91.87 |
| Otitis Media and Relapsing Polychondritis | Lifetime | 481 | US 114 | 88.44 |
| Lymphadenopathy Diagnosis and Analysis | Lifetime | 487 | US 93 | 37.47 |
| Dermatological and COVID-19 studies | 2021-2025 | 34 | US 6 | 91.47 |
| Cutaneous lymphoproliferative disorders research | 2021-2025 | 152 | US 55 | 93.17 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 237 | US 42 | 92.49 |
| Nail Diseases and Treatments | 2021-2025 | 254 | US 59 | 88.16 |
| Drug-Induced Adverse Reactions | 2021-2025 | 270 | US 74 | 85.09 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 463 | US 183 | 84.05 |
| Parvovirus B19 Infection Studies | 2021-2025 | 215 | US 66 | 80.33 |
| Cancer and Skin Lesions | 2021-2025 | 504 | US 159 | 73.99 |
| Vascular Tumors and Angiosarcomas | 2021-2025 | 541 | US 192 | 65.75 |
| Histiocytic Disorders and Treatments | 2021-2025 | 974 | US 305 | 21.65 |
